ASP Isotopes Implements Engineering Enhancements to Silicon-28 Enrichment Facility; Successfully Restarts First 18 Stages of Silicon-28 Enrichment Facility; Commercial Shipments of Enriched Silicon-28 Expected to Commence in Q3 2026

ASP Isotopes has previously announced that it has signed three commercial contracts for the supply of enriched Silicon-28 to U.S.-based customers, and expects to make initial commercial shipments of enriched Silicon-28 in Q3 2026. The first 18 stages (comprising segments one and two) of the Silicon-28 enrichment facility have now successfully operated for over three weeks at target enrichment levels.

GlobeNewsWire • May 26, 2026

ASP Isotopes Stock Surges After Silicon-28 Facility Restart

ASP Isotopes Inc. (NASDAQ:ASPI) shares are trading higher Tuesday after the company announced it restarted the first 18 states of its Silicon-28 enrichment facilities in Pretoria, South Africa.

Benzinga • May 26, 2026

ASP Isotopes Announces HALEU Supply MOU Through Subsidiary, Shares Move Higher

ASP Isotopes Inc. (NASDAQ:ASPI) shares are trading higher Monday after the company announced that its subsidiary, Quantum Leap Energy LLC, entered into a non-binding Memorandum of Understanding with a European nuclear technology company for advanced nuclear fuel supply collaboration.

Benzinga • May 11, 2026

Quantum Leap Energy Enters into Memorandum of Understanding with European Nuclear Technology Company for Advanced Nuclear Fuel Supply Collaboration

MOU establishes framework for collaboration with the goal to supply HALEU to European advanced reactor developer, beginning 2028 MOU establishes framework for collaboration with the goal to supply HALEU to European advanced reactor developer, beginning 2028

GlobeNewsWire • May 11, 2026

Quantum Leap Energy Appoints Dr. Peter Fiske to Strategic Advisory Board

Technology Commercialization Leader Expected to Enhance QLE's Government Partnerships and Advanced Materials Strategy Technology Commercialization Leader Expected to Enhance QLE's Government Partnerships and Advanced Materials Strategy

GlobeNewsWire • May 6, 2026

ASP Isotopes Inc. Provides Business Update

First Commercial Shipments Expected Across Multiple Isotopes in 2026 Expect to Obtain Helium Phase 1 Nameplate Capacity in Q3 2026 EBITDA Target of Greater Than $300 Million in 2031 Cash, Cash Equivalents and Short-Term Marketable Securities of $333 million as of December 31, 2025 Business Update Conference Call Scheduled for 8:00 AM ET on April 13, 2026 DALLAS, April 13, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) ("ASP Isotopes" or the "Company"), an advanced materials company focused on developing technologies and processes for the production of critical materials used in multiple industries, today provided a business update highlighting operational progress across its nuclear medicine, electronics, and nuclear energy platforms. “2026 is the year we expect to showcase our technology at scale.

GlobeNewsWire • Apr 13, 2026

ASP Isotopes to Host Business Update Conference Call on April 13, 2026, at 8:00 AM ET

DALLAS, April 10, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) ("ASP Isotopes" or the "Company"), an advanced materials company focused on developing technologies and processes for the production of critical materials used in multiple industries, today announced that Paul Mann, Executive Chairman and Chief Executive Officer at ASP Isotopes, will host a business update conference call and webcast on Monday, April 13, 2026, at 8:00 AM ET.

GlobeNewsWire • Apr 10, 2026

Did ASP Isotopes Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

PRNewsWire • Apr 9, 2026

Grabar Law Office Investigates Claims on Behalf of Investors of ASP Isotopes Inc. (ASPI) as Class Action Survives Motion to Dismiss

Philadelphia, Pennsylvania--(Newsfile Corp. - March 26, 2026) - What is Happening? Grabar Law Office is investigating claims on behalf of shareholders of ASP Isotopes Inc. ("ASP Isotopes" or the "Company") (NASDAQ: ASPI).

Newsfile Corp • Mar 26, 2026

ASP Isotopes Announces Strategic Collaboration Between Quantum Leap Energy and University of Bristol to Design Advanced Laser Research Facility

Collaboration to develop a cutting-edge lithium laser enrichment research facility in the UK Collaboration to develop a cutting-edge lithium laser enrichment research facility in the UK

GlobeNewsWire • Mar 24, 2026